---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-016000"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2026-05-11T23:59:59+00:00"
generated_at: "2026-05-14T19:18:34.759012+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical receives FDA clearance for power liposuction on AYON Body Contouring System

## Summary
- Expanded FDA 510(k) clearance for AYON Body Contouring System to include power liposuction, a reciprocating cannula for efficient fat removal.
- Power liposuction reduces surgeon effort and OR time; adds as second advanced liposuction modality on unified platform.
- Company plans limited commercial launch with early adopters to refine training and customer experience before scaling.
- CEO Charlie Goodwin says AYON becomes gold-standard system in surgical aesthetics with this clearance.

## SEC filing metadata
- accession: 0001437749-26-016000
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2026-05-11T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000143774926016000/0001437749-26-016000-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000143774926016000/apyx20260508_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-016000
- JSON: https://secwatch.observer/filing/0001437749-26-016000.json
- Plain text: https://secwatch.observer/filing/0001437749-26-016000.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.